Literature DB >> 6619033

Evaluation of azlocillin in vitro and in discriminative animal models of infection.

W M Scheld, J P Brodeur, J M Keeley, M R Field, W J Kelly, W J Long, O Zak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6619033     DOI： 10.1093/jac/11.suppl_b.51

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  4 in total

1.  Penetration of aztreonam into cerebrospinal fluid and brain of noninfected rabbits and rabbits with experimental meningitis caused by Pseudomonas aeruginosa.

Authors:  L J Strausbaugh; C R Bodem; P R Laun
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

2.  Cerebrospinal fluid ceftazidime kinetics in patients with external ventriculostomies.

Authors:  R Nau; H W Prange; M Kinzig; A Frank; A Dressel; P Scholz; H Kolenda; F Sörgel
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

3.  Comparison of ciprofloxacin with azlocillin plus tobramycin in the therapy of experimental Pseudomonas aeruginosa endocarditis.

Authors:  R W Strunk; J C Gratz; R Maserati; W M Scheld
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191

Review 4.  Rationale for optimal dosing of beta-lactam antibiotics in therapy for bacterial meningitis.

Authors:  W M Scheld
Journal:  Eur J Clin Microbiol       Date:  1984-12       Impact factor: 3.267
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.